Pregnancy and perinatal outcomes in women diagnosed with hydatidiform mole in a history

DOI: https://doi.org/10.29296/25877305-2018-08-05
Download full text PDF
Issue: 
8
Year: 
2018

Professor M. Zilber, MD; O. Grebneva, Candidate of Medical Sciences; Kh. Agayan; A. Volkova, Candidate of Medical Sciences Ural State Medical University

The paper analyzes the features of the course of pregnancy, as well as perinatal outcomes in patients after hydatidiform mole. The inconsistency of the data available in the literature may be partly due to different inclusion criteria and to the heterogeneity of the groups under consideration.
Keywords: 
obstetrics and gynecology
oncology
hydatidiform mole
trophoblastic disease
perinatal outcomes
pregnancy

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Sebire N., May R., Kaur V. et al. Abnormal villous morphology mimicking a hydatidiform mole associated with paternal trisomy of chromosomes 3,7,8 and unipaternal disomy of chromosome // Diagn. Pathol. – 20 16; 11: 20.
  2. Abaturov A.E. Vlijanie vrednyh privychek roditelej na genomnyj imprinting potomkov // Zdorov'e rebenka. – 2016; 6 (74): 115–8.
  3. Tempfer C., Horn L., Tempfer C. et al. Gestational and Non-gestational Trophoblastic Disease. Guidelines of the DGGG, OEGGG and SGGG // Obstetrics Frauenheilkd. – 2016; 76 (2): 134–44.
  4. Lebedev I.N., Sazhenova E.A., Lebedev I.N. Epimutatsii imprintirovannyh genov v genome cheloveka: klassifikatsija, prichiny vozniknovenija, svjaz' s nasledstvennoj patologiej // Genetika. – 2008; 44: 1356–73.
  5. Rahat B., Mahajan A., Bagga R., et al. Epigenetic modifications at DMRs of placental genes are subjected to variations in normal gestation, pathological conditions and folate supplementation // Sci. Rep. – 2017; 7: 407.
  6. Koh L.I. Puzyrnyj zanos. Vrachebnaja taktika // Sibirskij onkol. zhurn. – 2003; 3: 30–2.
  7. Coullin P., Diatta A., Boufettal H. et al. The involvement of the trans-generational effect in the high incidence of the hydatidiform mole in Africa // Placenta. – 2015; 36: 48–51.
  8. Messerli M., Lilienfeld A., Parmley T. et al. Risk factors for gestational trophoblastic neoplasia // Am. J. Obstet. Gynecol. – 1985; 153: 294–300.
  9. Tsip N.P. Puzyrnyj zanos: faktory riska // Onkologija. – 2002; 1: 74–7.
  10. Parazzini F., Cipriani S., Mangili G. et al. Oral contraceptives and risk of gestational trophoblastic disease // Contraception. – 2002; 65 (6): 425–7.
  11. Toloknov B.O., Mahova E.E., Laktionov K.T., i dr. Immunnyj status u patsientok s trofoblasticheskoj bolezn'ju // Opuholi zhenskoj reproduktivnoj sistemy. – 2009; 1–2: 63–7.
  12. Mescherjakova, L.A., Mescherjakova L.A., Kuznetsov V.V. i dr. Chastichnyj puzyrnyj zanos i beremennost'. Mat-ly konf. «Aktual'nye voprosy zhenskogo zdorov'ja», Moskva, 28–29 oktjabrja 2014 g. / M., 2014; s. 23–4.
  13. Kitange B., Matovelo D., Konje E. et al. Hydatidiform moles among patients with incomplete abortion in Mwanza City, North western Tanzania // Afr. Health Sci. – 2015; 15 (4): 1081–6.
  14. Bahidze E.V. Epidemiologija trofoblasticheskoj bolezni. Klassifikatsija i prognosticheskie faktory. Printsipy diagnostiki // Prakt. onkologija. – 2008; 9 (3): 137–44.
  15. Vlijanie vrednyh privychek roditelej na genomnyj imprinting potomkov // Zdorov'e rebenka. – 2016; 6 (74): 115–8.
  16. Alisheva B.N., Atykanov A.O. Strukturno-funktsional'noe sostojanie kletochnyh membran pri trofoblasticheskoj bolezni u zhenschin reproduktivnogo vozrasta // Vestn. Kyrgyzskogo-Rossijskogo slavjanskogo universiteta. – 2010; 10 (7): 121–5.
  17. Bystritskaja D.A., Tihonovskaja M.N., Mescherjakova L.A. i dr. Trofoblasticheskie opuholi: k voprosu o klassifikatsii (chast' I) // Ros. onkol. zhurn. – 2014; 1: 54–6.
  18. Li X., Du D., Chen S. et al. Trends in ectopic pregnancy, hydatidiform mole and miscarriage in the largest obstetrics and gynaecology hospital in China from 2003 to 2013 // Reprod. Health. – 2016; 13 (1): 58.
  19. Tse K., Ngan H. Gestational trophoblastic disease // Best Pract. Res. Clin. Obstet. Gynaecol. – 2012; 26 (3): 357–70.
  20. Sebire N., Sebire N., Fisher R. et al. Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy // BJOG. – 2003; 110: 22–6.
  21. Matsui H., Iitsuka Y., Suzuka K. et al. Subsequent pregnancy outcome in patients with spontaneous resolution of HCG after evacuation of hydatidiform mole: comparison between complete and partial mole // Hum. Reprod. – 2001; 16 (6): 1274–7.
  22. Eagles N., Sebire N., Short D. et al. Risk of recurrent molar pregnancies following complete and partial hydatidiform moles // Hum. Reprod. – 2015; 30 (9): 2055–63.
  23. Patil Sh., Narshetty J., Singh G. et al. Recurrent hydatiform mole: a rare case report // Intern. J. Reprod., Contracept., Obstet. Gynecol. – 2013; 2 (3): 433–6.
  24. Ngan H., Kohorn E., Cole L. et al. Trophoblastic disease // Int. J. Gynaecol. Obstet. – 2012; 119 (2): 130–6.
  25. Gestational Trophoblastic Disease Treatment (PDQ®)–Health Professional Version National Cancer Institute in USA. [elektronnyj resurs]: https://www.cancer.gov/types/gestational-trophoblastic/patient/gtd-treatment-pdq
  26. Gestational trophoblastic disease. [elektronnyj resurs]: http://www.slhd.nsw.gov.au/services/sgog/GTD_G uide.html
  27. Kerkmeijer L., Wielsma S., Massuger L. et al. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands // Gynecol. Oncol. – 2007; 106: 142–6.
  28. Candelier J.-J. The hydatidiform mole // Cell MIGR AZ. – 2016; 10 (1–2): 226–35.
  29. Kani K., Lee J., Dighe M. et al. Gestatational trophoblastic disease: multimodality imaging assessment with special emphasis on spectrum of abnormalities and value of imaging in staging and management of disease // Curr. Probl. Diagn. Radiol. – 2012; 41 (1): 1–10.
  30. Savage P., Sita-Lumsden A., Dickson S. et al. The relationship of maternal age to molar pregnancy incidence, risks for chemotherapy and subsequent pregnancy outcome // J. Obstet. Gynaecol. – 2013; 33 (4): 406–11.
  31. Toloknov B.O., Martyshina Ja.A., Mahova E.E. i dr. Trofoblasticheskaja bolezn' i beremennost' // Vestn. RONTs im. N.N. Blohina RAMN. – 2009; 20 (2): 90–3.
  32. Garrett L., Garner E., Feltmate C. et al. Subsequent pregnancy outcome in patients with molar pregnancy and persistent gestational trophoblastic neoplasia // J. Reprod. Med. – 2008; 53: 481–6.
  33. Stevens F., Katzorke N., Tempfer C. et al. Gestational Trophoblastic Disorders: An Update in 2015 // Geburtshilfe Frauenheilkd. – 2015; 75 (10): 1043–50.
  34. Uberti E., Fajardo C., Ferreira S. et al. Reproductive outcome after discharge of patients with high-risk hydatidiform mole with or without use of one bolus dose of actinomycin D, as prophylactic chemotherapy, during the uterine evacuation of molar pregnancy // Gynecol. Oncol. – 2009; 115 (3): 476–81.
  35. Tse K., Ngan H. Gestational trophoblastic disease // Best Pract. Res. Clin. Obstet. Gynaecol. – 2012; 26 (3): 357–70.
  36. Gadducci I., Lanfredini N., Cosio S. Reproductive outcomes after hydatiform moles and gestational trophoblast neoplasia // Gynecol. Endocrinol. – 2015; 31 (9): 673–8.
  37. Markina I.V., Mahova E.E., Toloknov B.O. i dr. Osobennosti vedenija patsientok, perenesshih puzyrnyj zanos. Mat-ly XXIV Mezhdunar. kongressa s kursom endoskopii «Novye tehnologii v diagnostike i lechenii ginekologicheskih zabolevanij» / M., 2011; s. 228–9.
  38. Braga I., Maesta I., Michelin O. et al. Maternal and perinatal outcomes of first pregnancy after chemotherapy for gestational trophoblastic neoplasia in Brazilian women // Gynecol. Oncol. – 2009; 112 (3): 568–71.
  39. Matsui H., Iitsuka Y., Suzuka K. et al. Subsequent pregnancy outcome in patients with spontaneous resolution of HCG after evacuation of hydatidiform mole: comparison between complete and partial mole // Hum. Reprod. – 2001; 16 (6): 1274–7.
  40. Horn L., Kowalzik J., Bilek K. et al. Clinicopathological characteristics and subsequent pregnancy outcome in 139 complete hydatidiform mole // Eur. J. Obstet. Gynecol. Reprod. Biol. – 2006; 128 (1–2): 10–4.
  41. Joneborg U., Eloranta S., Johansson A. et al. Hydatidiform mole and subsequent pregnancy outcome: a population-based cohort study // Am. J. Obstet. Gynecol. – 2014; 211 (6): 681–3.